Article Details

Subcutaneous Pertuzumab and Trastuzumab Combo for HER2-Positive Early Breast Cancer ...

Retrieved on: 2021-01-26 18:56:15

Tags for this article:

Click the tags to see associated articles and topics

Subcutaneous Pertuzumab and Trastuzumab Combo for HER2-Positive Early Breast Cancer .... View article details on hiswai:

Excerpt

“The results of this study add to the current knowledge regarding the subcutaneous delivery of monoclonal antibodies in oncology by confirming that ...

Article found on: www.cancernetwork.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up